Cargando…

The threshold model revisited

BACKGROUND: The threshold model represents one of the most significant advances in the field of medical decision‐making, yet it often does not apply to the most common class of clinical problems, which include health outcomes as a part of definition of disease. In addition, the original threshold mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Djulbegovic, Benjamin, Hozo, Iztok, Mayrhofer, Thomas, van den Ende, Jef, Guyatt, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590161/
https://www.ncbi.nlm.nih.gov/pubmed/30575227
http://dx.doi.org/10.1111/jep.13091
_version_ 1783429498277986304
author Djulbegovic, Benjamin
Hozo, Iztok
Mayrhofer, Thomas
van den Ende, Jef
Guyatt, Gordon
author_facet Djulbegovic, Benjamin
Hozo, Iztok
Mayrhofer, Thomas
van den Ende, Jef
Guyatt, Gordon
author_sort Djulbegovic, Benjamin
collection PubMed
description BACKGROUND: The threshold model represents one of the most significant advances in the field of medical decision‐making, yet it often does not apply to the most common class of clinical problems, which include health outcomes as a part of definition of disease. In addition, the original threshold model did not take a decision‐maker's values and preferences explicitly into account. METHODS: We reformulated the threshold model by (1) applying it to those clinical scenarios, which define disease according to outcomes that treatment is designed to affect, (2) taking into account a decision‐maker's values. RESULTS: We showed that when outcomes (eg, morbidity) are integral part of definition of disease, the classic threshold model does not apply (as this leads to double counting of outcomes in the probabilities and utilities branches of the model). To avoid double counting, the model can be appropriately analysed by assuming diagnosis is certain (P = 1). This results in deriving a different threshold—the threshold for outcome of disease (M (t) ) instead of threshold for probability of disease (P (t) ) above which benefits of treatment outweigh its harms. We found that M (t) ≤ P (t), which may explain differences between normative models and actual behaviour in practice. When a decision‐maker values outcomes related to benefit and harms differently, the new threshold model generates decision thresholds that could be descriptively more accurate. CONCLUSIONS: Calculation of the threshold depends on careful disease versus utility definitions and a decision‐maker's values and preferences.
format Online
Article
Text
id pubmed-6590161
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65901612019-07-08 The threshold model revisited Djulbegovic, Benjamin Hozo, Iztok Mayrhofer, Thomas van den Ende, Jef Guyatt, Gordon J Eval Clin Pract Original Papers BACKGROUND: The threshold model represents one of the most significant advances in the field of medical decision‐making, yet it often does not apply to the most common class of clinical problems, which include health outcomes as a part of definition of disease. In addition, the original threshold model did not take a decision‐maker's values and preferences explicitly into account. METHODS: We reformulated the threshold model by (1) applying it to those clinical scenarios, which define disease according to outcomes that treatment is designed to affect, (2) taking into account a decision‐maker's values. RESULTS: We showed that when outcomes (eg, morbidity) are integral part of definition of disease, the classic threshold model does not apply (as this leads to double counting of outcomes in the probabilities and utilities branches of the model). To avoid double counting, the model can be appropriately analysed by assuming diagnosis is certain (P = 1). This results in deriving a different threshold—the threshold for outcome of disease (M (t) ) instead of threshold for probability of disease (P (t) ) above which benefits of treatment outweigh its harms. We found that M (t) ≤ P (t), which may explain differences between normative models and actual behaviour in practice. When a decision‐maker values outcomes related to benefit and harms differently, the new threshold model generates decision thresholds that could be descriptively more accurate. CONCLUSIONS: Calculation of the threshold depends on careful disease versus utility definitions and a decision‐maker's values and preferences. John Wiley and Sons Inc. 2018-12-21 2019-04 /pmc/articles/PMC6590161/ /pubmed/30575227 http://dx.doi.org/10.1111/jep.13091 Text en © 2018 The Authors Journal of Evaluation in Clinical Practice Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Djulbegovic, Benjamin
Hozo, Iztok
Mayrhofer, Thomas
van den Ende, Jef
Guyatt, Gordon
The threshold model revisited
title The threshold model revisited
title_full The threshold model revisited
title_fullStr The threshold model revisited
title_full_unstemmed The threshold model revisited
title_short The threshold model revisited
title_sort threshold model revisited
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590161/
https://www.ncbi.nlm.nih.gov/pubmed/30575227
http://dx.doi.org/10.1111/jep.13091
work_keys_str_mv AT djulbegovicbenjamin thethresholdmodelrevisited
AT hozoiztok thethresholdmodelrevisited
AT mayrhoferthomas thethresholdmodelrevisited
AT vandenendejef thethresholdmodelrevisited
AT guyattgordon thethresholdmodelrevisited
AT djulbegovicbenjamin thresholdmodelrevisited
AT hozoiztok thresholdmodelrevisited
AT mayrhoferthomas thresholdmodelrevisited
AT vandenendejef thresholdmodelrevisited
AT guyattgordon thresholdmodelrevisited